About Pricing FAQs Blog

Loading clinical trials...

Your health journey, clearly organized.

Find Clinical Trials →

Legal

Privacy Policy
Terms of Service

© 2026 Clareo Health. All rights reserved.

Impact of ILM Peeling in RRD/ I-Peel | Clinical Trials | Clareo Health

Back to clinical trial search

Active Not RecruitingNANCT04767555

Impact of ILM Peeling in RRD/ I-Peel

Retinal detachment is associated with a substantial risk of re-detachment in 10-20% and to the formation of secondary epiretinal membranes in up to 15%. Relevant postoperative vision loss is encounter...

Lead sponsor: Berner Augenklinik•1 locations•View source on ClinicalTrials.gov

Clareo plain-language summary

What this study is about

Generating AI summary...

Clareo turns complex medical information into clear understanding you can use.

Bring this clarity to your next appointment.

Keep all your medical notes and next steps in one place.

Start Free Trial

Sponsors

Lead Sponsor

Berner Augenklinik

Age

18 - 110 years

Sex

ALL

Healthy Volunteers

No

Inclusion Criteria

•primary rhegmatogenous retinal detachment
•of legal age (18 years or older)
•in case of bilateral retinal detachment, only the first-affected eye will be included

Exclusion Criteria

•pre-existing functional and morphological changes to the macula, hindering visual recovery (amblyopia, trauma, macular degeneration)
•advanced retinal detachment with PVR stage C2 or more
•eyes pre-operated within six months prior to the development of RD
•state after any vitreoretinal surgery
•state after complicated cataract surgery, including aphakia and anterior chamber lens implantation
•patients with increased risk profiles
•myopia magna (≥7 diopters)
•advanced diabetic retinopathy
•any chronic ocular or systemic inflammatory disease
•any other proliferative systemic disease or condition associated with impaired wound healing

Related studies

Spring Loaded Syringe for Active Silicon Oil Extraction

NCT07363889 · Retinal Detachment

1ry Versus 2ry ILM Peeling in RD

NCT07346560 · Retinal Detachment Rhegmatogenous, ILM Peeling

Intraoperative OCT Guidance of Intraocular Surgery II

NCT03713268 · Macular Holes, Epiretinal Membrane, and more

RECRUITINGPhase 4

Dropless Pars Plana Vitrectomy Study

NCT05331664 · Rhegmatogenous Retinal Detachment

RECRUITINGPhase 3

Treatment of Retinal Detachment in People Who Have Not Had Cataract Surgery With Vitrectomy vs Vitrectomy and Cataract Removal

NCT06997874 · Rhegmatogenous Retinal Detachment

View all related studies →

Data from ClinicalTrials.govLast updated on ClinicalTrials.gov: December 8, 2025Terms

Trial snapshot

StatusACTIVE_NOT_RECRUITING

PhaseNA

Enrollment250

Start dateFeb 2022

Last updatedDec 8, 2025

Condition

Retinal Detachment

Locations shown

Berner Augenklinik

Bern, Canton of Bern

For caregivers

Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.

Start free trial →

Data Source & Attribution

This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.

ClinicalTrials.gov last update: December 8, 2025Data synced to Clareo: May 10, 2026

Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.

Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.

View ClinicalTrials.gov Terms and Conditions